Gabriela Łocik

Gabriela Łocik

Auto-generated profile, based on publicly available information

Gabriela Łocik

Wolski Hospital named after dr Anna Gostyńska, Marcina Kasprzaka 17, 01-211 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DADamian Adasik
Damian Adasik
MBMarta Bonarska
Marta Bonarska
GŁGabriela Łocik
Gabriela Łocik
SSSimone Szymczyk
Simone Szymczyk
KKKacper Król
Kacper Król
Background: Mood disorders, including major depressive disorder (MDD) and anxiety disorders, significantly impact global mental health, contributing to disability and reduced quality of life. While pharmacotherapy and psychotherapy are standard treatments, many patients experience residual symptoms or treatment resistance. Aerobic exercise has emerged as a promising adjunctive intervention due to its psychological and neurobiological benefits. This review examines its efficacy, mechanisms, optimal implementation strategies, and integration into psychiatric care.Methods: A narrative literature review was conducted using PubMed, Embase, and other relevant databases, focusing on studies published up to 2025. Keywords such as "aerobic exercise," "depression," "anxiety," "psychiatric disorders," and "neurobiological mechanisms" were used to identify studies assessing clinical outcomes, neurobiological effects, and adherence factors.Results: Aerobic exercise significantly reduces depression and anxiety symptoms across diverse populations, with moderate-to-large effect sizes in randomized controlled trials. Mechanistically, it enhances neurotransmitter balance, increases brain-derived neurotrophic factor (BDNF), regulates the hypothalamic-pituitary-adrenal (HPA) axis, and improves cognitive function. Optimal outcomes are observed with moderate-intensity exercise (60–80% HRmax), performed three times per week for at least 8–12 weeks. Supervised and group-based interventions improve adherence, particularly in psychiatric populations.Conclusions: Aerobic exercise represents a viable, low-cost, and effective adjunct to traditional psychiatric treatments. However, methodological limitations, lack of long-term data, and adherence challenges remain. Future research should focus on standardized protocols, personalized exercise prescriptions, and large-scale, multi-center trials to maximize clinical integration and optimize patient outcomes.

15 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KDKacper Dywan
Kacper Dywan
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
PKPaweł Kukiełka
Paweł Kukiełka
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Introduction and Purpose: Plantar fasciitis (PF) is one of the most common causes of heel pain in adults, with a lifetime incidence of about 10%. Diagnosis is primarily clinical, based on patient history and physical examination. This study aims to present and compare treatment modalities for PF, including conservative and surgical options. Brief Description of the State of Knowledge: The plantar fascia is a dense connective tissue crucial for supporting the medial longitudinal arch and enabling efficient gait. PF most often affects individuals aged 45–65 and is frequently associated with elevated body mass index. A characteristic symptom is sharp heel pain upon rising in the morning, which improves with walking. Physical examination may include the Silfverskiöld test to assess gastrocnemius contracture. Imaging, such as radiography, ultrasonography, or MRI, can support diagnosis. Although PF often recurs, 85–90% of patients respond to conservative treatment. Historically, management relied on night splints, orthoses, NSAIDs, and corticosteroid injections. Current strategies emphasize stretching and strengthening exercises. Surgical treatment is reserved for refractory cases. Materials and methods: In this article, we utilized scientific literature describing various treatment approaches for patients with PF. Particular attention was given to diagnostic strategies and the appropriate use of imaging modalities. Treatment efficacies were compared, and potential adverse effects were also discussed. Conclusions: Multiple therapies for PF show similar efficacy. Conservative management should remain first-line, with surgery considered when nonoperative measures fail. Successful outcomes depend on individualized treatment, patient education, and adherence. Collaboration between orthopedic surgeons and physiotherapists plays a key role in optimizing care.

17 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MMMartyna Musiorska
Martyna Musiorska
JMJulia Mazurek
Julia Mazurek
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Introduction and purpose: Rathke’s cleft cysts (RCCs) are benign, epithelium-lined lesions located in the sellar or suprasellar region, originating from remnants of Rathke’s pouch. While often asymptomatic and discovered incidentally, RCCs may lead to significant clinical symptoms due to compression of adjacent structures, including the pituitary gland and optic chiasm. The aim of this review is to provide a comprehensive overview of RCCs and emphasize the importance of accurate diagnosis and individualized management, especially in symptomatic cases. Material and methods: The review is based on scientific literature published between 2005 and 2025, retrieved from PubMed, Scopus and Google Scholar using the following keywords: “Rathke’s cleft cyst,”, “Rathke’s cyst diagnosis,” “Rathke’s cyst treatment,” “pituitary cyst surgery,” and “Rathke’s cyst recurrence”. Results: Analysis of the literature indicates that although most RCCs remain asymptomatic, a significant subset causes symptoms such as headaches, visual disturbances, and endocrine dysfunction. MRI remains the most effective diagnostic tool, while treatment typically involves transsphenoidal surgical drainage. Recurrence rates vary depending on the surgical technique and inflammatory changes within the cyst wall. Emerging approaches, such as steroid-eluting stents, show promise in reducing recurrence, though further research is needed. Conclusions: RCCs, though generally benign, may result in substantial morbidity in symptomatic patients. Accurate diagnosis, appropriate imaging, and tailored treatment are essential for optimal outcomes. Long-term follow-up is recommended due to the potential for recurrence, and novel interventions offer promising avenues for future management strategies.

14 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PKPaweł Kukiełka
Paweł Kukiełka
KMKatarzyna Moliszewska
Katarzyna Moliszewska
JKJoanna Kośka
Joanna Kośka
KDKacper Dywan
Kacper Dywan
MBMichał Błaszkiewicz
Michał Błaszkiewicz
GŁGabriela Łocik
Gabriela Łocik
Background:Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously classified under non-alcoholic fatty liver disease (NAFLD), is an increasingly prevalent chronic liver disorder tightly linked to obesity, insulin resistance, and systemic metabolic dysfunction. It ranges from simple steatosis to nonalcoholic steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. Objective:This review explores the current understanding of MASLD, emphasizing its multifactorial etiology, evolving pathophysiological mechanisms, clinical progression, and therapeutic strategies, including emerging pharmacological and lifestyle interventions. Methods:A structured review of peer-reviewed articles published between 2019 and 2025 was conducted using critical analysis of uploaded and curated literature focusing on MASLD’s pathogenesis, comorbidities, and treatment modalities. Findings:MASLD is driven by a combination of genetic, environmental, metabolic, and immunological factors. Recent insights into lipid dysregulation, gut-liver axis, immune modulation, and endocrine pathways have clarified mechanisms of disease progression. Weight loss remains a cornerstone of management, supported by emerging anti-obesity medications such as GLP-1 receptor agonists and dual agonists. Novel therapies targeting hepatic stellate cells, fibroinflammatory signaling, and microbiota-derived metabolites represent future avenues for precision-based treatment. Conclusion:Effective MASLD management necessitates an integrated approach combining lifestyle interventions, pharmacotherapy, and targeted therapeutics based on individual phenotypes. Continued research into molecular pathways and personalized strategies holds promise for disease reversal and improved patient outcomes.

28 July 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PAPiotr Armański
Piotr Armański
KHKatarzyna Herjan
Katarzyna Herjan
GŁGabriela Łocik
Gabriela Łocik
MBMarta Bonarska
Marta Bonarska
JWJoanna Wróbel
Joanna Wróbel
KJKlaudia Jedlina
Klaudia Jedlina
Introduction: Hyaluronic acid (HA) is a long, unbranched polysaccharide classified as a glycosaminoglycan. Since its isolation from the vitreous body of an ox in 1934 by Karl Meyer and John Palmer, HA has attracted considerable interest across medical disciplines. Naturally occurring HA possesses several favorable properties, including high water-binding capacity, biocompatibility, viscoelasticity, free radical scavenging, and unique rheological characteristics. It also exhibits anti-inflammatory, antiangiogenic, and immunosuppressive effects, contributing to its increasing popularity—especially in orthopedics. HA is present in high concentrations within synovial fluid, joint capsules, and cartilage, making it highly relevant in conditions involving joint degeneration or injury. Accordingly, HA-based therapies have found widespread application in treating osteoarthritis, rheumatoid arthritis, tendinopathies, and other soft tissue disorders. Aim: The aim of this work is to evaluate the clinical relevance, efficacy, and safety of hyaluronic acid (HA) in the treatment of orthopedic conditions, particularly osteoarthritis, tendinopathies, and other soft tissue injuries. The objective is to clarify HA's therapeutic value, especially via intra-articular injection, amid ongoing debate regarding its clinical effectiveness compared to placebo and standard non-surgical treatments. Materials and Methods: This review is based on an analysis of numerous studies, particularly randomized controlled trials (RCTs), that assessed the efficacy of HA in orthopedic applications. Emphasis was placed on comparing HA treatment outcomes—most notably intra-articular injections—with those of placebo and conventional non-operative therapies. Literature was reviewed from relevant medical databases and peer-reviewed sources. Results: Evidence from multiple studies suggests that intra-articular HA injections can lead to improvements in pain and joint function compared to baseline or non-surgical treatments. However, many randomized controlled trials have shown no statistically significant advantage of HA over placebo. Despite this, patient-reported outcomes often indicate symptom relief and improved function following HA administration. Conclusion: Due to conflicting data regarding its clinical utility, the use of HA in orthopedics remains a topic of ongoing debate. Nonetheless, HA's favorable safety profile and biological properties support its consideration in selected orthopedic cases. When used appropriately, HA injections may offer a viable non-surgical option for managing joint and soft tissue disorders.

13 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KMKatarzyna Moliszewska
Katarzyna Moliszewska
PKPaweł Kukiełka
Paweł Kukiełka
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
JMJulia Mazurek
Julia Mazurek
MBMichał Błaszkiewicz
Michał Błaszkiewicz
BackgroundThe human gut microbiome—a dynamic ecosystem of bacteria, viruses, fungi, and archaea—is integral to digestion, immune modulation, metabolism, and systemic health. Its composition is shaped by perinatal factors, genetics, environment, diet, physical activity, and probiotic interventions. Modulating the microbiome through lifestyle and nutritional strategies offers potential for disease prevention and enhanced athletic performance. AimThis review synthesizes current evidence on factors influencing gut microbiota composition across the lifespan, the systemic impacts of dysbiosis, and the roles of diet, physical activity, and probiotics—particularly in athletic populations—in fostering a health-promoting microbiome. Material and MethodsA narrative review was conducted using peer-reviewed studies, meta-analyses, and clinical trials sourced from PubMed, Scopus, and Web of Science. Topics included microbiome development, lifestyle and dietary influences, exercise-related microbiome adaptations, and probiotic applications. ResultsPerinatal factors such as delivery mode, breastfeeding, and antibiotics shape early microbiota with long-term health effects. Diet is a primary modulator: fiber- and polyphenol-rich diets enhance microbial diversity, whereas high-protein, low-fiber diets may impair gut health in athletes. Physical activity modifies microbiota structure and function; regular exercise promotes beneficial SCFA-producing taxa, strengthens gut barrier integrity, and supports immune and neurocognitive health. Probiotic supplementation improves gastrointestinal and dermatological conditions, modulates inflammation, and enhances athletic recovery and resilience. ConclusionsThe gut microbiome is a key determinant of systemic health. Targeted diet, structured physical activity, and personalized probiotic use can optimize microbiota function. In athletes, integrating microbiome profiling with individualized nutrition may enhance performance and recovery.